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Recent  outbreaks  of  enterovirus  in  Southeast  Asia 
emphasize difficulties in diagnosis of this infection. To ad-
dress this issue, we report 5 (4.7%) children infected with 
enterovirus 75 among 106 children with acute encephalitis 
syndrome during 2005–2007 in southern India. Throat swab 
specimens may be useful for diagnosis of enterovirus 75 
infection. 
S
equences of enterovirus 75 (EV75) were first identi-
fied in cerebrospinal fluid (CSF), stool samples, and 
throat  samples  obtained  during  1974–2000  in  Ethiopia, 
Oman, Bangladesh, and the United States; the new entero-
virus serotype was proposed in 2004 (1). Manifestations 
include upper respiratory tract infections and acute flaccid 
paralysis. In 2005–2006, EV75 was associated with aseptic 
meningitis in Spain (2,3). Enteroviruses have long been as-
sociated with encephalitis, but recent outbreaks of EV71 in 
Southeast Asia have highlighted the diagnostic difficulties 
that may be encountered (4–6). We report EV75 associated 
with encephalitis in India.
The Study
We prospectively studied children <16 years of age 
who came to the Pediatric Department at the Vijayanagar 
Institute of Medical Sciences, Bellary, Karnataka, south-
ern India, with acute encephalitis syndrome during October 
2005–December 2007. Children with acute fever and symp-
toms with an onset <14 days before coming to the hospital, 
a neurologic illness, and >1 of the following signs (change 
in mental status including confusion, disorientation, coma, 
or inability to talk; new onset of seizures excluding simple 
febrile  seizures;  photophobia,  headache,  or  meningitis) 
were recruited into the study. Children with laboratory-
confirmed Plasmodium falciparum parasitemia or a history 
of neurologic conditions and those whose parents removed 
them from the hospital were excluded. The study protocol 
was reviewed and approved by the ethics committees of 
Vijayanagar Institute of Medical Sciences and the Univer-
sity of Liverpool, UK. Informed consent was obtained from 
parents or guardians.
For each child, a completed medical history was ob-
tained and a detailed physical examination was performed. 
Samples were obtained for routine diagnostics. Rectal and 
throat samples were also collected after December 2005. 
Swabs were placed in sterile vials containing viral culture 
media (Dulbecco’s modified Eagle’s medium). All samples 
were frozen at –20°C, stored at –70°C, and transferred to 
diagnostic laboratories.
To detect enteroviruses, including EV75, in throat swab 
extracts, RNA was extracted by using the Chemagic Viral 
DNA/RNA kit (Chemagen AG, Baesweiler, Germany) and 
a Kingfisher mL Magnetic Extractor (Thermo Fisher Sci-
entific Inc., Waltham, MA, USA). Pan-enterovirus reverse 
transcription–PCR (RT-PCR) was then performed by using 
primers specific for the 5′ untranslated region (5′-ATT GTC 
ACC ATA AGC AGC CA-3′ and 5′-CCT CCG GCC CCT 
GAA TGC GGC TAA T-3′); these primers produced a 154-
bp product (7). Enteroviruses identified by pan-enterovirus 
RT-PCR were typed by nucleotide sequencing of the viral 
protein 1 (VP1) region (8,9).
To further type enteroviruses, phylogenetic analysis 
was performed on all nucleotide sequences (from this study 
and others obtained from GenBank) by using MEGA4 soft-
ware (10) (www.megasoftware.net). The remaining swab 
transport medium was filtered, and 100 μL of filtrate was 
aliquoted onto each of 3 tissue culture plates containing 
rhabdomyosarcoma, Vero, and 293T cell lines for virus 
isolation. Cell lines were chosen to facilitate culturing of 
a range of viruses that may have been responsible for the 
clinical spectrum of illness seen.
Because CSF volume for virus isolation was limited to 
a 100-μL sample, this sample was placed on rhabdomyo-
sarcoma cells for isolation and identification of enterovi-
ruses. All CSF and serum samples were tested by using an 
immunoglobulin M capture ELISA to detect antibodies to 
Japanese encephalitis virus (JEV) and dengue virus, which 
circulate in the study region (11). If a sufficient amount of 
CSF remained, RNA was extracted by using the Viral RNA 
Mini Extraction Kit (QIAGEN, Hilden, Germany) accord-
ing to the manufacturer’s instructions for pan-enterovirus 
RT-PCR, as described above and for a JEV RT-PCR (7,12). 
Plasma samples were also tested for chikungunya virus by 
using RT-PCR (13).
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Of 243 children recruited into the study, 3 died before 
diagnostic samples could be obtained and 8 left the hospi-
tal against medical advice before samples were obtained. 
Among 232 children who satisfied the inclusion criteria, 
166 CSF samples were obtained from 152 children. We 
also obtained 108 throat swabs specimens from 106 chil-
dren and 19 rectal swab specimens from 18 children from 
the 171 children recruited after December 2005 when swab 
sampling began.
Virus isolates from throat swabs of 5 (4.7%) of 106 pa-
tients with a clinical signs of acute encephalitis syndrome 
were positive by pan-enterovirus RT-PCR for EV75. Se-
quencing indicated that VP1 regions of virus isolates ob-
tained were similar to those of EV75. The 5 EV75-positive 
children were admitted to hospital on days 1–6 (median 4 
days) of illness (Table). These children had a median age 
of 8 years (range 1.5–10 years), and 3 were girls. All 5 
children had severe clinical disease (drowsiness, irritabil-
ity, and reduced consciousness) at the time of admission, 
and 3 had seizures before admission.
Lumbar puncture was performed for 4 of the 5 chil-
dren. Laboratory values were within reference ranges for 
2 children, leukocyte counts were increased for 3 children, 
and results were not available for 1 child. The child for 
whom no lumbar puncture was performed had neurologic 
deterioration, meningism, and bilateral papilloedema; this 
child was treated empirically.
Sequencing showed that VP1 region homology for vi-
rus isolated in this study was similar to that observed for 
previously  identified  EV75  isolates  (Figure).  Sufficient 
CSF  sample  for  pan-enterovirus  RT-PCR  was  available 
for 162 samples from 162 patients, including 4 of the 5 
EV75-positive patients; all samples were negative for JEV. 
These 162 samples were also negative for enteroviruses by 
pan-enterovirus RT-PCR (7,12). Serum samples from the 
5 EV75-positive patients were negative for JEV and den-
gue virus by immunoglobulin M capture ELISA, for JEV 
by RT-PCR, and for chikungunya virus by RT-PCR. Eight 
patients showed positive results for chikungunya virus by 
RT-PCR, 48 showed positive results for JEV by ELISA, 
and 12 showed positive results for dengue virus by ELISA 
(14).
Conclusions
Enteroviruses are a diverse group, and preferred sam-
ples for their diagnosis differ. Species B enteroviruses such 
as coxsackie virus A9 and Echo viruses B1–6 are usually 
readily isolated from CSF, unlike species A enteroviruses 
such as EV71. Although EV75 is a species B enterovirus, 
we were unable to isolate enterovirus from CSF from any 
of the patients, although throat swabs specimens were posi-
tive. This finding is similar to that for EV71, which has 
been isolated more frequently from throat swab specimens 
than from CSF or vesicles (4). In a study from Spain, EV75 
was isolated from the CSF of 5 patients and nasopharynge-
al swab specimens of 3 patients (3). However, throat swab 
specimens are rarely obtained in rural hospital settings with 
limited diagnostic facilities.
Although EV75 infection may have been a coinciden-
tal finding for the patients, we believe that this possibility 
is unlikely because results for other common causes of en-
cephalitis were negative. Results of CSF testing were nega-
tive for other circulating viruses, including JEV, dengue 
virus, and herpes simplex virus, and patients also showed 
negative results for JEV and dengue virus by ELISA. 
Our results illustrate the need to confirm diagnoses of 
EV75 in a range of specimens and by a range of labora-
tory investigations. This confirmation is required in India 
where encephalitis is often diagnosed clinically and recent 
outbreaks have been attributed to JEV. Laboratory diagno-
sis is hampered by single samples and high cost and low 
reliability of diagnostic tests currently available. Our study 
also shows that EV75 can cause encephalitis, in addition to 
aseptic meningitis and acute flaccid paralysis. Thus, as for 
other enteroviruses, throat swab specimens may be espe-
cially useful for diagnosis of infection with EV75.
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Table. Characteristics and samples tested for 5 patients with confirmed enterovirus 75 infection, southern India* 
Patient
no. Age, y/sex 
Illness duration/length 
of hospital stay, d  Clinical signs† 
Sample tested for 
EV75
1 6/F  6/7 5 d of fever and rigors, 3 d of headache, 2 d of neck pain and 
cough, and 1 d of photophobia. Drowsy and irritable with brisk 
reflexes on admission. 
Throat swab and 
CSF 
2 1.5/M 8/8 8 d of fever, rigors, coryzal symptoms, drowsiness, and mouth 
twitching; and 3 episodes of GTC seizures of 5–10 min duration. 
Still vacant and communication reduced at discharge. 
Throat swab and 
CSF 
3 10/F  3/5 3 d of fever, headache, and vomiting; 2 d of drowsiness at home; 
and 1 episode of GTC convulsion at home. 
Throat swab 
4 8/M 8/7 8 d of fever, headache, neck pain, cough, vomiting, and reduced 
speech and irritability. Irritable at discharge. 
Throat swab and 
CSF 
5 8/F  2/1 2 d of fever and 1 episode of GTC convulsion at home lasting 30 
min.
Throat swab and 
CSF 
*EV75, enterovirus 75; CSF, cerebrospinal fluid; GTC, generalized tonic clonic. 
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Figure. Phylogenetic analysis of viral protein 1 enterovirus 75 (EV75) 
nucleotide  sequences.  The  tree  was  constructed  by  using  the 
neighbor-joining method and the maximum-composite likelihood-
substitution model. Significance of phylogenies was investigated by 
bootstrap analysis with 1,000 pseudoreplicate datasets. Bootstrap 
values  >70%  are  indicated  on  the  tree.  Closed  circles  indicate 
isolates from India (this study) and open circles previously reported 
EV75 sequences. All EV75 sequences are named by using the 
conventional GenBank accession numbers (published sequences) 
or sample name (sequences from this study), country of origin, 
and year of isolation (where available). All prototype EV reference 
sequences  are  indicated  by  their  GenBank  accession  numbers 
preceding  serotype  identification.  Scale  bar  indicates  nucleotide 
substitutions per site.
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